Article List

WPRIM Management System> DCMS> Philippine Journal of Neurology> 2012> 16> 1

Volume: 16 Issue: 1

1. Botulinum toxin therapy as early intervention in post-stroke upper limb spasticity.	Page:21—29
2. Prevalence and risk factors for the development of dyskinesia among Filipino patients with Parkinson's disease: A 7 year retrospective study.	Page:49—
3. Meta-analysis of rasagiline as monotherapy in early Parkinson's disease.	Page:52—
4. Case series study of Japanese B encephalitis patients admitted at Philippine Children's Medical Center from January 2011 to April 2012.	Page:54—
5. Suicide among patients with X-linked dystonia parkinsonism (XDP): A retrospective study.	Page:53—
6. Efficacy and safety of 24 hour rotigotine transdermal patch in the treatment of advanced Parkinson's disease: A meta-analysis.	Page:53—
7. Efficacy and safety of 24 hour rotigotine transdermal rotigotine patch in the treatment of early Parkinson's disease.	Page:52—
8. Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system.	Page:51—
9. A meta-analysis on the effect of topiramate in essential tremor.	Page:50—
10. Hemichorea and myoclonus in Filipino patients with cerebral toxoplasmosis: A report of two cases.	Page:50—
11. A rare disease with a unique feature: Anti-NMDA receptor encephalitis and mesenteric teratoma.	Page:49—
12. Botulinum toxin therapy in established post-stroke upper limb spasticity .	Page:31—36
13. The promise of deep brain stimulation in X-linked dystonia parkinsonism.	Page:83—89
14. Oral pharmacological treatment of X-linked dystonia parkinsonism: Successes and failures.	Page:79—82
15. Understanding XDP through imaging,pathology,and genetics.	Page:73—78
16. Uncovering the mystery from the Philippine Island of Panay.	Page:61—62
17. Rapid response of methylprednisone in a 14 year old male with proven anti-NMDA a receptor encephalitis.	Page:54—55
18. A Randomized, double-blind, placebo-controlled study comparing the efficacy, safety and tolerability of levodopa-carbidopa versus placebo in patients with X-linked dystonia-parkinsonism (XDP).	Page:53—54
19. Anxiety symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease.	Page:51—52
20. Montreal cognitive assessment (MoCA) and mini-mental state examination (MMSE) as screening tools for cognitive impairment among patients with idiopathic Parkinson's disease: A descriptive study.	Page:50—51
21. Botulinum toxin-A targeted for focal/ multifocal dystonias- An open- label application in X-linked Dystonia-Parkinsonism.	Page:37—45
22. Management of non-motor symptoms in Parkinson's disease.	Page:5—20
23. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag") .	Page:63—71
24. Experience with zolpidem in childhood dystonia.	Page:55—